We are live on ! Find out more
AT

Arvest Trust Portfolio holdings

AUM $1.68B
1-Year Est. Return 14.24%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+14.24%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$915M
AUM Growth
+$41.4M
Cap. Flow
-$10.8M
Cap. Flow %
-1.18%
Top 10 Hldgs %
38.19%
Holding
112
New
13
Increased
21
Reduced
56
Closed
5

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$16.3M
2
DRI icon
Darden Restaurants
DRI
+$14.1M
3
EFA icon
iShares MSCI EAFE ETF
EFA
+$1.34M
4
SWN
Southwestern Energy Company
SWN
+$1.22M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$625K

Top Sells

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$16.7M
2
GILD icon
Gilead Sciences
GILD
+$13.8M
3
WMT icon
Walmart Inc
WMT
+$10.2M
4
COP icon
ConocoPhillips
COP
+$1.07M
5
XOM icon
ExxonMobil
XOM
+$310K

Sector Composition

Rank Sector Weight
1 Healthcare 11.77%
2 Technology 11%
3 Financials 8.61%
4 Energy 7.98%
5 Consumer Staples 7.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDY icon
1
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$26.6B
$81.1M 8.87%
358,362
-299
-0.1% -$66.5K
EFA icon
2
iShares MSCI EAFE ETF
EFA
$78B
$53.1M 5.8%
831,628
+21,792
+3% +$1.34M
IWM icon
3
iShares Russell 2000 ETF
IWM
$79.8B
$30.3M 3.31%
284,149
+4,447
+2% +$460K
COP icon
4
ConocoPhillips
COP
$147B
$23.2M 2.53%
333,121
-16,063
-5% -$1.07M
TJX icon
5
TJX Companies
TJX
$174B
$20.9M 2.28%
741,112
-5,346
-0.7% -$142K
LOW icon
6
Lowe's Companies
LOW
$117B
$20.2M 2.21%
423,747
-3,061
-0.7% -$139K
ACN icon
7
Accenture
ACN
$102B
$19.4M 2.12%
262,974
-1,839
-0.7% -$136K
UNP icon
8
Union Pacific
UNP
$174B
$19.1M 2.08%
245,334
-1,782
-0.7% -$141K
BIIB icon
9
Biogen
BIIB
$30B
$17.7M 1.94%
73,623
-74,799
-50% -$16.7M
AGN
10
DELISTED
Allergan plc
AGN
$17.7M 1.93%
+122,320
New +$16.3M
RTX icon
11
RTX Corp
RTX
$290B
$16.9M 1.85%
249,376
-1,448
-0.6% -$94.8K
AAPL icon
12
Apple
AAPL
$4.54T
$16.3M 1.79%
959,448
-6,664
-0.7% -$110K
DIS icon
13
Walt Disney
DIS
$167B
$16.1M 1.76%
250,259
-1,854
-0.7% -$119K
CVS icon
14
CVS Health
CVS
$133B
$16M 1.75%
281,260
-2,007
-0.7% -$120K
STX icon
15
Seagate
STX
$194B
$15.6M 1.71%
357,206
+343
+0.1% +$14.4K
AXP icon
16
American Express
AXP
$227B
$14.8M 1.62%
195,623
-1,317
-0.7% -$99.1K
IBM icon
17
IBM
IBM
$211B
$14.8M 1.62%
83,443
-461
-0.5% -$83.8K
T icon
18
AT&T
T
$159B
$14.7M 1.6%
573,649
-5,940
-1% -$156K
GILD icon
19
Gilead Sciences
GILD
$162B
$14.5M 1.58%
230,526
-230,447
-50% -$13.8M
JNJ icon
20
Johnson & Johnson
JNJ
$618B
$14.5M 1.58%
166,867
-1,351
-0.8% -$121K
BDX icon
21
Becton Dickinson
BDX
$45.6B
$14.2M 1.55%
145,453
-1,032
-0.7% -$101K
CL icon
22
Colgate-Palmolive
CL
$73.1B
$14.1M 1.54%
237,711
+194
+0.1% +$11.5K
DRI icon
23
Darden Restaurants
DRI
$23.3B
$13.5M 1.47%
+325,714
New +$14.1M
TGT icon
24
Target
TGT
$65.6B
$13.4M 1.46%
209,065
-1,528
-0.7% -$104K
SPY icon
25
State Street SPDR S&P 500 ETF Trust
SPY
$790B
$13.2M 1.44%
78,410
+3,727
+5% +$625K
1
2 3 4

Similar funds

BPCA
Bank Pictet & Cie (Asia) Singapore $1.57B AUM 25.56% 1-Year Est. Return
CDH
Charles D. Hyman $1.79B AUM 17.18% 1-Year Est. Return
HIG
Herr Investment Group Austin, Texas $1.5B AUM 29.27% 1-Year Est. Return
H
HoyleCohen San Diego, California $1.32B AUM 27.05% 1-Year Est. Return
PRIG
Payden & Rygel Investment Group Los Angeles, California $1.24B AUM
PO
Private Ocean San Rafael, California $1.13B AUM 11.01% 1-Year Est. Return
LFDLE
La Financiere de L'Echiquier Paris, France $2.29B AUM 37.29% 1-Year Est. Return
GP
Girard Partners King Of Prussia, Pennsylvania $1.06B AUM 17.26% 1-Year Est. Return

Arvest Trust's Q3 2013 Portfolio in Review

As of Q3 2013, Arvest Trust held 112 positions worth $915M, up 4.7% from $873M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Arvest Trust's Q3 2013 filing shows 13 new, 21 increased, 56 reduced and 5 closed positions. Its largest new stake was Allergan plc: 122,320 shares worth $17.7M. The largest sale was Biogen, an estimated $16.7M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 13% a quarter earlier, followed by Technology and Financials.

  • Arvest Trust's largest Q3 2013 buy was Allergan plc: 122,320 shares worth $17.7M.
  • Arvest Trust added most to iShares MSCI EAFE ETF in Q3 2013, an estimated $1.34M increase.
  • Arvest Trust's biggest Q3 2013 reduction was Biogen, cutting an estimated $16.7M.
  • Arvest Trust fully exited Oneok Partners LP in Q3 2013, selling an estimated $266K.
  • Arvest Trust's ten largest holdings make up 38% of its $915M portfolio in Q3 2013.
  • Arvest Trust opened 13 new positions and closed 5 in Q3 2013.
  • Arvest Trust's portfolio value rose 4.7% quarter-over-quarter to $915M.

Based on Arvest Trust's 13F filing for Q3 2013, filed 21 Nov 2013.